Title : US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though
link : US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though
US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though
So, it's not just Astra Zeneca, Moderna and Pfizer. It's Johnson and Johnson too.
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.
The reports appear similar to a rare, unusual type of clotting disorder that European authorities say is possibly linked to another COVID-19 vaccine not yet cleared in the U.S., from AstraZeneca.
AstraZeneca is being used widely here in Canada.
CDC's Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation into the cause of the clots and low platelet counts.
Officials say they also want to educate vaccine providers and health professionals about the "unique treatment" required for this type of clot.
"Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," Dr. Anne Schuchat, principal deputy director of the CDC, and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a joint statement.
They are recommending that people who were given the J&J vaccine who are experiencing severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after receiving the shot contact their health care provider.
U.S. health authorities cautioned doctors against using a typical clot treatment, the blood-thinner heparin. "In this setting, administration of heparin may be dangerous and alternative treatments need to be given," the FDA and CDC said.
Johnson & Johnson said it was aware of the reports of "thromboembolic events," or blood clots, but that no link to its vaccine had been established.
"We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines," said Johnson & Johnson in a statement. "At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine."
States swiftly moved Tuesday morning to implement the pause. New York state health commissioner Dr. Howard Zucker said the state will follow the recommendation and pause the use of the Johnson & Johnson vaccine at state-run sites. People with Tuesday appointments for Johnson & Johnson vaccines at state-run mass vaccination sites will instead get the Pfizer vaccine, he said.
Thus Article US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though
You are now reading the article US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though with the link address https://darmonewst.blogspot.com/2021/04/us-johnson-johnson-vaccine-pause-due-to.html
0 Response to "US Johnson & Johnson Vaccine Pause due to Multiple Clot Reports- Astra Zeneca Not Used in US- Ok'd for Canada, though"
Post a Comment